FindTrial
Sign In

effect of dexmedetomedine with ropivacaine for ultrasound guided serratus anterior block in patients undergoing modified radical mastectomy for post op pain relief .

Effect of dexmedetomidine as adjuvant to ropivacaine for ultra sound guided serratus anterior plane block in patients undergoing modified radical mastectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036676
Enrollment
60
Registered
2021-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: GP D will receive 0.5 % ropivacaine (0.5ml/kg) with 2ml dexmedetomedinie (1 microgm/kg) via USG guided serratus anterior block .: 30 patients in GP D posted for modified radical maste

Sponsors

gcs medical college hospital and rsearch centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I and ASA 2 Patients age >20 years BMI <30kg/m2

Exclusion criteria

Exclusion criteria: Prexisting bleeding coagulation disorders morbid obesity local inflammation st the site of block study drug allergy patient with clinical significant cardiac,pulmonary ,renal or heptic disease history of opioid addiction patient refusal

Design outcomes

Primary

MeasureTime frame
post op pain score NRS at rest an don hand abduction ,total dose of intra -op opioid consumption Timepoint: at 0, 1, 2, 4, 6, 12, 24, 48 hr post operatively—

Secondary

MeasureTime frame
total dose of rescue analgesia required post operatively in 48 hr, time to first rescue analgesia post operatively, sedation score, any side effects nausea ,vomting etcTimepoint: at 0,1, 2, 4, 6, 12, 48 hr.—

Countries

India

Contacts

Public Contactdr reema wadhawa

gcs medical college hospital and research centre

reema.tavar@gmail.com9911358590

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026